Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lidocaine-prilocaine cream for CPAP mask comfort in obstructive sleep apnea
IRCT20190602043791N1Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Nov 2019
- Modality
- Small Molecules, Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3, single-blind trial of lidocaine + prilocaine in obstructive sleep apnea hypopnea syndrome (OSAHS) (3 arms), sponsored by Tehran University of Medical Sciences. Primary endpoint: Patient comfort using the CPAP mask. Started Nov 2019; status: completed.
02
Drugs
lidocaine + prilocaine
03
Conditions
obstructive sleep apnea hypopnea syndrome (OSAHS)
Beyond the preview
Go deeper on IRCT20190602043791N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190602043791N1.